28395912|t|Dobutamine Stress Echocardiography: Impact of Abnormal Blood Potassium Levels on Cardiac Arrhythmias
28395912|a|Guidelines suggest that an abnormal blood potassium level is a relative contraindication to performing dobutamine stress echocardiography (DSE). However, this has not been previously studied. We reviewed a consecutive series of patients who had potassium testing within 48 hours of undergoing DSE for the evaluation of myocardial ischemia over a 10- year period (N = 13,198). Normal potassium range in our laboratory is 3.6-5.2 mmol/L. Hemolyzed samples were not included. The association of potassium levels with the development of supraventricular and ventricular arrhythmias was assessed. The incidence of clinically significant arrhythmias was very low (supraventricular tachycardia / atrial fibrillation, 4.9%; nonsustained ventricular tachycardia, 2.9%; sustained ventricular tachycardia or ventricular fibrillation, 0.1%), confirming the overall safety of DSE. Most arrhythmias (88%) occurred in patients with normal potassium levels, and arrhythmia rates remained low in patients with potassium abnormalities. Patients with hyperkalemia had a lower risk of developing mild (odds ratio [OR], 0.39; 95% CI, 0.22-0.71) and severe (OR, 0.13; 95% CI, 0.01-0.68) supraventricular arrhythmias as well as mild ventricular arrhythmias (OR, 0.58; 95% CI, 0.40-0.83). Even though events were rare, patients with severe hypokalemia (potassium levels ≤ 3.1 mmol/L) had an increased risk of supraventricular arrhythmia and ventricular ectopy. DSE is safe even in the setting of abnormalities in blood potassium concentrations, and hence cancellation of DSE in patients with potassium abnormalities does not appear warranted. Elevated potassium levels are associated with lower rates of clinically significant supraventricular and ventricular arrhythmias. While remaining at relatively low risk, patients with very low potassium levels (≤3.1 mmol/L) at the time of DSE have a modestly increased risk of arrhythmia. Consideration could be given to correcting severe hypokalemia prior to DSE.
28395912	0	34	Dobutamine Stress Echocardiography	T058	UMLS:C0949700
28395912	46	54	Abnormal	T033	UMLS:C0205161
28395912	55	77	Blood Potassium Levels	T033	UMLS:C1261540
28395912	81	100	Cardiac Arrhythmias	T033	UMLS:C0003811
28395912	101	111	Guidelines	T170	UMLS:C0162791
28395912	128	136	abnormal	T033	UMLS:C0205161
28395912	137	158	blood potassium level	T033	UMLS:C1261540
28395912	204	238	dobutamine stress echocardiography	T058	UMLS:C0949700
28395912	240	243	DSE	T058	UMLS:C0949700
28395912	307	337	consecutive series of patients	T062	UMLS:C2985408
28395912	346	355	potassium	T103	UMLS:C0032821
28395912	394	397	DSE	T058	UMLS:C0949700
28395912	406	416	evaluation	T058	UMLS:C0220825
28395912	420	439	myocardial ischemia	T038	UMLS:C0151744
28395912	484	493	potassium	T103	UMLS:C0032821
28395912	507	517	laboratory	T092	UMLS:C0022877
28395912	537	554	Hemolyzed samples	T033	UMLS:C0475880
28395912	593	609	potassium levels	T033	UMLS:C0428289
28395912	634	650	supraventricular	T038	UMLS:C0428974
28395912	655	678	ventricular arrhythmias	T038	UMLS:C0085612
28395912	733	744	arrhythmias	T033	UMLS:C0003811
28395912	759	787	supraventricular tachycardia	T038	UMLS:C0039240
28395912	790	809	atrial fibrillation	T038	UMLS:C0004238
28395912	817	853	nonsustained ventricular tachycardia	T038	UMLS:C2919575
28395912	861	894	sustained ventricular tachycardia	T038	UMLS:C0750197
28395912	898	922	ventricular fibrillation	T038	UMLS:C0042510
28395912	964	967	DSE	T058	UMLS:C0949700
28395912	974	985	arrhythmias	T033	UMLS:C0003811
28395912	1025	1041	potassium levels	T033	UMLS:C0428289
28395912	1047	1057	arrhythmia	T033	UMLS:C0003811
28395912	1094	1103	potassium	T103	UMLS:C0032821
28395912	1104	1117	abnormalities	T033	UMLS:C1704258
28395912	1133	1145	hyperkalemia	T033	UMLS:C0020461
28395912	1266	1294	supraventricular arrhythmias	T038	UMLS:C0428974
28395912	1311	1334	ventricular arrhythmias	T038	UMLS:C0085612
28395912	1417	1428	hypokalemia	T033	UMLS:C0020621
28395912	1430	1446	potassium levels	T033	UMLS:C0428289
28395912	1486	1513	supraventricular arrhythmia	T038	UMLS:C0428974
28395912	1518	1536	ventricular ectopy	T038	UMLS:C0012634
28395912	1538	1541	DSE	T058	UMLS:C0949700
28395912	1573	1586	abnormalities	T033	UMLS:C1704258
28395912	1590	1620	blood potassium concentrations	T033	UMLS:C1261540
28395912	1648	1651	DSE	T058	UMLS:C0949700
28395912	1669	1678	potassium	T103	UMLS:C0032821
28395912	1679	1692	abnormalities	T033	UMLS:C1704258
28395912	1729	1745	potassium levels	T033	UMLS:C0428289
28395912	1804	1820	supraventricular	T038	UMLS:C0428974
28395912	1825	1848	ventricular arrhythmias	T038	UMLS:C0085612
28395912	1913	1929	potassium levels	T033	UMLS:C0428289
28395912	1959	1962	DSE	T058	UMLS:C0949700
28395912	1997	2007	arrhythmia	T033	UMLS:C0003811
28395912	2059	2070	hypokalemia	T033	UMLS:C0020621
28395912	2080	2083	DSE	T058	UMLS:C0949700